Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 4
2016 1
2017 3
2018 7
2019 5
2020 12
2021 5
2022 10
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hu yao huang (35 results)?
Clinical characteristics and medical service utilization of lung cancer in China, 2005-2014: Overall design and results from a multicenter retrospective epidemiologic survey.
Shi JF, Wang L, Wu N, Li JL, Hui ZG, Liu SM, Yang BY, Gao SG, Ren JS, Huang HY, Zhu J, Liu CC, Fan JH, Zhao SJ, Xing PY, Zhang Y, Li N, Lei WD, Wang DB, Huang YC, Liao XZ, Xing XJ, Du LB, Yang L, Liu YQ, Zhang YZ, Zhang K, Qiao YL, He J, Dai M; LuCCRES Group. Shi JF, et al. Lung Cancer. 2019 Feb;128:91-100. doi: 10.1016/j.lungcan.2018.11.031. Epub 2018 Nov 24. Lung Cancer. 2019. PMID: 30642458
Landscape and progress of global COVID-19 vaccine development.
Huang HY, Wang SH, Tang Y, Sheng W, Zuo CJ, Wu DW, Fang H, Du Q, Li N. Huang HY, et al. Hum Vaccin Immunother. 2021 Oct 3;17(10):3276-3280. doi: 10.1080/21645515.2021.1945901. Epub 2021 Jul 13. Hum Vaccin Immunother. 2021. PMID: 34254894 Free PMC article. Review.
Rare tumors: a blue ocean of investigation.
Wang S, Ma P, Jiang N, Jiang Y, Yu Y, Fang Y, Miao H, Huang H, Tang Q, Cui D, Fang H, Zhang H, Fan Q, Wang Y, Liu G, Yu Z, Lei Q, Li N. Wang S, et al. Among authors: huang h. Front Med. 2023 Apr;17(2):220-230. doi: 10.1007/s11684-023-0984-z. Epub 2023 Apr 26. Front Med. 2023. PMID: 37185946 Review.
Clinical development of mRNA therapies against solid tumors.
Wu D, Hu L, Wang X, Yu Y, Jia SP, Huang HY, Li ZW, Ma JF, Zhu HB, Tang Y, Li N. Wu D, et al. J Hematol Oncol. 2023 Jul 18;16(1):75. doi: 10.1186/s13045-023-01457-x. J Hematol Oncol. 2023. PMID: 37464375 Free PMC article.
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials.
Wang S, Yang Y, Ma P, Huang H, Tang Q, Miao H, Fang Y, Jiang N, Li Y, Zhu Q, Tao W, Zha Y, Li N. Wang S, et al. Among authors: huang h. Mol Ther Oncolytics. 2022 Feb 22;24:799-813. doi: 10.1016/j.omto.2022.02.019. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2022. PMID: 35317518 Free PMC article. Review.
Clinical development of immuno-oncology in China.
Wu DW, Huang HY, Tang Y, Zhao Y, Yang ZM, Wang J, Wang SH, Yu Y, Fang Y, Fang H, Bai Y, Sun C, Fan Q, Yu AQ, Wang HL, Du CX, Chen K, Huang MD, Zhang Y, Li N, Xu BH, Sun Y, He J. Wu DW, et al. Lancet Oncol. 2020 Aug;21(8):1013-1016. doi: 10.1016/S1470-2045(20)30329-6. Lancet Oncol. 2020. PMID: 32758460 No abstract available.
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC.
Li Y, Zhou A, Liu S, He M, Chen K, Tian Z, Li Y, Qin J, Wang Z, Chen H, Tian H, Yu Y, Qu W, Xue L, He S, Wang S, Bie F, Bai G, Zhou B, Yang Z, Huang H, Fang Y, Li B, Dai X, Gao S, He J. Li Y, et al. Among authors: huang h. BMC Med. 2023 Mar 8;21(1):86. doi: 10.1186/s12916-023-02804-y. BMC Med. 2023. PMID: 36882775 Free PMC article. Clinical Trial.
57 results